 Therefore, for the primary triple end-point of deathMIstroke ischemic with 180 evaluable patients, we will have an 80 power at a two-sided alpha level of 0.05 to detect a statistical significant difference in the 2 groups if the rate of events in the UFH group is 30 and on tinzaparin is 13 or less. 